QNTM
Quantum Biopharma-B Sub Vot
NASDAQ · Pharmaceuticals
$4.20
+0.28 (+7.14%)
Open$3.96
Previous Close$3.92
Day High$4.29
Day Low$3.90
52W High$10.81
52W Low$5.40
Volume—
Avg Volume720.3K
Market Cap20.18M
P/E Ratio12.49
EPS$0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+125.7% upside
Current
$4.20
$4.20
Target
$9.48
$9.48
$6.03
$9.48 avg
$10.62
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.61M | 6.92M | 6.74M |
| Net Income | 1.84M | 1.19M | 1.39M |
| Profit Margin | 24.2% | 17.2% | 20.6% |
| EBITDA | 2.64M | 2.30M | 2.54M |
| Free Cash Flow | 1.03M | 1.07M | 803.7K |
| Rev Growth | +16.6% | +5.5% | +24.9% |
| Debt/Equity | 0.64 | 0.65 | 0.79 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |